Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa Patients
Status:
Terminated
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The study will investigate efficacy of STW5-II as add-on therapy on the rate to remission in
patients with mild to moderate ulcerative colitis in an acute flare.